Table 2.
Schedule of enrolment, interventions, and assessments
| TIMEPOINT | STUDY PERIOD | ||||
|---|---|---|---|---|---|
| Enrolment | Baseline | Intervention | Follow-up | ||
| T0 | T1 | T2 | |||
| ENROLMENT: | |||||
| Eligibility screen | X | ||||
| Informed consent | X | ||||
| Allocation | X | ||||
| INTERVENTIONS: | |||||
| Intervention group | X | ||||
| Control group | X | ||||
| ASSESSMENTS: | |||||
| Primary outcome | |||||
| Medication adherence (MARS-5) | X | X | X | ||
| Secondary outcomes | |||||
| Medication knowledge (PKMUQ) | X | X | X | ||
| Medication beliefs (BMQ) | X | X | X | ||
| Medication social support (MSSS) | X | X | X | ||
| Medication self-efficacy (SEAMS) | X | X | X | ||
| Medication skills (self-developed scale) | X | X | X | ||
| Medication treatment satisfaction (TSQM) | X | X | X | ||
| Treatment burden (TBQ) | X | X | X | ||
| Quality of life (EQ-5D-5L) | X | X | X | ||
| Utilisation of healthcare services (six-item questionnaire) | X | X | |||
| Potential covariates | |||||
| Socio-demographics (Patients questionnaire) | X | ||||
| Number of prescribed medications (one-item question) | X | ||||
| Disease burden (CIRS-G) | X | ||||
| Depressive symptoms (PHQ-9) | X | ||||